Marina Ruiz de Galarreta

Marina Ruiz de Galarreta

Auto-generated profile, based on publicly available information

Marina Ruiz de Galarreta

Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
MGMarina Ruiz de Galarreta
Marina Ruiz de Galarreta
EBErin Bresnahan
Erin Bresnahan
PMPedro Molina-Sánchez
Pedro Molina-Sánchez
KLKatherine E. Lindblad
Katherine E. Lindblad
BMBarbara Maier
Barbara Maier
ALAmaia Lujambio
Amaia Lujambio
PD-1 immune checkpoint inhibitors have produced encouraging results in patients with hepatocellular carcinoma (HCC). However, what determines resistance to anti–PD-1 therapies is unclear. We created a novel genetically engineered mouse model of HCC that enables interrogation of how different genetic alterations affect immune surveillance and response to immunotherapies. Expression of exogenous antigens in MYC;Trp53−/− HCCs led to T cell–mediated immune surveillance, which was accompanied by decreased tumor formation and increased survival. Some antigen-expressing MYC;Trp53−/− HCCs escaped the immune system by upregulating the β-catenin (CTNNB1) pathway. Accordingly, expression of exogenous antigens in MYC;CTNNB1 HCCs had no effect, demonstrating that β-catenin promoted immune escape, which involved defective recruitment of dendritic cells and consequently impaired T-cell activity. Expression of chemokine CCL5 in antigen-expressing MYC;CTNNB1 HCCs restored immune surveillance. Finally, β-catenin–driven tumors were resistant to anti–PD-1. In summary, β-catenin activation promotes immune escape and resistance to anti–PD-1 and could represent a novel biomarker for HCC patient exclusion. Significance: Determinants of response to anti–PD-1 immunotherapies in HCC are poorly understood. Using a novel mouse model of HCC, we show that β-catenin activation promotes immune evasion and resistance to anti–PD-1 therapy and could potentially represent a novel biomarker for HCC patient exclusion. See related commentary by Berraondo et al., p. 1003. This article is highlighted in the In This Issue feature, p. 983

23 June 2022 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
AZAndrew X. Zhu
Andrew X. Zhu
AAAlexander R. Abbas
Alexander R. Abbas
MGMarina Ruiz de Galarreta
Marina Ruiz de Galarreta
YGYinghui Guan
Yinghui Guan
SLShan Lu
Shan Lu
YWYulei Wang
Yulei Wang

1 September 2014 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
EAElena Arriazu
Elena Arriazu
MGMarina Ruiz de Galarreta
Marina Ruiz de Galarreta
Francisco Javier CuberoFrancisco Javier Cubero
Francisco Javier Cubero
MVMarta Varela-Rey
Marta Varela-Rey
MOMaría Pilar Pérez de Obanos
María Pilar Pérez de Obanos
NNNatalia Nieto
Natalia Nieto
Significance: The extracellular matrix (ECM) is a dynamic microenvironment that undergoes continuous remodeling, particularly during injury and wound healing. Chronic liver injury of many different etiologies such as viral hepatitis, alcohol abuse, drug-induced liver injury, obesity and insulin resistance, metabolic disorders, and autoimmune disease is characterized by excessive deposition of ECM proteins in response to persistent liver damage. Critical Issues: This review describes the main collagenous and noncollagenous components from the ECM that play a significant role in pathological matrix deposition during liver disease. We define how increased myofibroblasts (MF) from different origins are at the forefront of liver fibrosis and how liver cell-specific regulation of the complex scarring process occurs. Recent Advances: Particular attention is paid to the role of cytokines, growth factors, reactive oxygen species, and newly identified matricellular proteins in the regulation of fibrillar type I collagen, a field to which our laboratory has significantly contributed over the years. We compile data from recent literature on the potential mechanisms driving fibrosis resolution such as MF’ apoptosis, senescence, and reversal to quiescence. Future Directions: We conclude with a brief description of how epigenetics, an evolving field, can regulate the behavior of MF and of how new “omics” tools may advance our understanding of the mechanisms by which the fibrogenic response to liver injury occurs. Antioxid. Redox Signal. 21, 1078–1097.

1 August 2016 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
MGMarina Ruiz de Galarreta
Marina Ruiz de Galarreta
ANAmaia Navarro
Amaia Navarro
EAEduardo Ansorena
Eduardo Ansorena
AGAntonia García Garzón
Antonia García Garzón
TMTeresa Mòdol
Teresa Mòdol
MIMaria J. Iraburu
Maria J. Iraburu

27 June 2014 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
TMTeresa Mòdol
Teresa Mòdol
NBNatalia Brice
Natalia Brice
MGMarina Ruiz de Galarreta
Marina Ruiz de Galarreta
AGAntonia García Garzón
Antonia García Garzón
MIMaria J. Iraburu
Maria J. Iraburu
MLMaría J. López‐Zabalza
María J. López‐Zabalza

18 September 2017 in Food & Function
Verified
Journal Article
Closed access
PDF file
PAPaula Aranaz
Paula Aranaz
AHAna Romo Hualde
Ana Romo Hualde
MZMaría Zabala
María Zabala
DNDavid Navarro-Herrera
David Navarro-Herrera
MGMarina Ruiz de Galarreta
Marina Ruiz de Galarreta
CGCarlos Javier González-Navarro
Carlos Javier González-Navarro
Obesity and type 2-diabetes are becoming a worldwide health problem, reiterating the importance of alternative therapies to tackle their progression. Here, we hypothesized that supplementation of diet with 6% w/w of a freeze-dried strawberry–blueberry (5 : 1) powder (FDSB) could exert beneficial metabolic effects on Wistar rats. FDSB-supplemented animals experienced significantly reduced body weight gain, food efficiency and visceral adiposity accumulation in two independent experiments. FDSB supplementation also contributed to lower area under the curve after an intraperitoneal GTT and reduced serum insulin levels and an insulin resistance index (IR-HOMA) in HFS diet-fed animals, together with reduced plasma MCP-1 inflammation marker concentrations. Gene expression analysis in retroperitoneal adipocytes from experiment 1 and 3T3-L1 cells showed that FDSB inhibited adipogenesis and lipogenesis through down-regulation of Pparg, Cebpa, Lep, Fasn, Scd-1 and Lpl gene expression. Untargeted metabolomics identified the cis isomer of resveratrol-3-glucoside-sulphate as a metabolite differentially increased in FDSB-treated serum samples, which corresponds to a strawberry metabolite that could be considered a serum biomarker of FDSB-intake. Our results suggest that FDSB powder might be useful for treatment/prevention of obesity-related diseases.